Literature DB >> 14007214

Serum haptoglobin in liver disease.

R WILLIAMS, B E SPEYER, B H BILLING.   

Abstract

Serum haptoglobin levels have been measured in 115 cases of widely differing liver disease. Although low levels were found in some cases of cirrhosis and a number of patients with obstructive jaundice had increased levels, 70% of the values fell within the normal range. The estimation was of no help in distinguishing between intra- and extrahepatic obstructive jaundice. A characteristic pattern was observed in infective hepatitis, and a falling serum haptoglobin in the presence of increasing jaundice is diagnostic of the latter condition. The cause of these changes is uncertain. Low levels could not be accounted for by increased red cell breakdown and there was no correlation with the serum albumin level. Prednisolone therapy produced a rise in serum haptoglobin level in cirrhosis, which was accompanied by an improvement in liver function. Temporary rises in level were observed in intrahepatic obstructive jaundice and were probably due to a non-specific effect of prednisolone. In the latter condition norethandrolone therapy was often associated with high levels.

Entities:  

Keywords:  LIVER DISEASES/blood; MUCOPROTEINS/chemistry

Mesh:

Substances:

Year:  1961        PMID: 14007214      PMCID: PMC1413362          DOI: 10.1136/gut.2.4.297

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Serum haptoglobins in hepatobiliary disease.

Authors:  J A OWEN; I R MACKAY
Journal:  Br Med J       Date:  1959-06-06

2.  Genetic control of human haptoglobin synthesis.

Authors:  A C ALLISON
Journal:  Nature       Date:  1959-05-09       Impact factor: 49.962

3.  The haptoglobin content of serum in haemolytic anaemia.

Authors:  I BRUS; S M LEWIS
Journal:  Br J Haematol       Date:  1959-10       Impact factor: 6.998

4.  A simple method for the determination of serum haptoglobins.

Authors:  J A OWEN; F C BETTER; J HOBAN
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

5.  Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults.

Authors:  O SMITHIES
Journal:  Biochem J       Date:  1955-12       Impact factor: 3.857

6.  The liver and steroid hormone metabolism.

Authors:  C B CAMERON
Journal:  Br Med Bull       Date:  1957-05       Impact factor: 4.291

7.  The problem of chronic liver disease in young women.

Authors:  A G BEARN; H G KUNKEL; R J SLATER
Journal:  Am J Med       Date:  1956-07       Impact factor: 4.965

8.  [Seromucoids in blood: relation to mucoproteins of the ground substance of connective tissue].

Authors:  M F JAYLE; G BOUSSIER
Journal:  Expos Annu Biochim Med       Date:  1955

9.  [Variations of the plasma protein formula during liver diseases].

Authors:  M F JAYLE; J VALLIN
Journal:  Sem Hop       Date:  1952-10-22

10.  The determination of haptoglobins in normal human serum.

Authors:  H Smith; J A Owen
Journal:  Biochem J       Date:  1961-04       Impact factor: 3.857

View more
  5 in total

Review 1.  [Clinical significance of haptoglobin].

Authors:  H J Braun
Journal:  Blut       Date:  1972-02

2.  [Clinical significance of quantitative serum hemopexin assessment as compared with that of haptoglobin].

Authors:  H J Braun; F W Aly
Journal:  Klin Wochenschr       Date:  1971-04-15

3.  DIAGNOSTIC VALUE OF SERUM HAPTOGLOBIN.

Authors:  N K SHINTON; R W RICHARDSON; J D WILLIAMS
Journal:  J Clin Pathol       Date:  1965-01       Impact factor: 3.411

4.  Proteomic analysis of serum and urine of HIV-monoinfected and HIV/HCV-coinfected patients undergoing long term treatment with nevirapine.

Authors:  Jeerang Wongtrakul; Thananya Thongtan; Sittiruk Roytrakul; Benjawan Kumrapich; Kanokwan Janphen; Jutarat Praparattanapan; Khuanchai Supparatpinyo; Duncan R Smith
Journal:  Dis Markers       Date:  2014-12-17       Impact factor: 3.434

5.  CHANGES IN SERUM ALPHA-2 GLOBULINS IN RETICULOSES.

Authors:  J S MALPAS; G H FAIRLEY
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.